Chambers Global ranks Yuval Horn as a leading Israeli practitioner in M&A: High Tech
March 1, 2013
Yuval Horn nominated as Chairperson of the IBA LifeSciences SubCommittee.
December 1, 2012
Immune Pharmaceuticals Ltd., and EpiCept Corporation entere into a definitive merger agreement.
November 8, 2012
Yuval Horn chairs a panel at the IBA Annual Conference in Dublin, Ireland (October 2012).
October 6, 2012
ANTI CORRUPTION REGULATION 2012
August 6, 2012
THE INTERNATIONAL WHO’S WHO OF LIFE SCIENCES LAWYERS 2013
August 6, 2012
Pfizer, Inc. and Protalix BioTherapeutics, Inc. announce that the FDA approved ELELYSO™.
May 6, 2012
ILS Brokers Ltd.’s shareholders sell all of their shares to Leader Capital Markets Ltd.
May 6, 2012
Protalix BioTherapeutics, Inc. raised over $25 million on AMEX.
February 6, 2012
A merger of Gardia Medical Ltd. with Allium Medical Solutions Ltd.
January 6, 2012
